Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial

Journal of Internal Medicine(2022)10.1111/joim.13553Source: DataRank Database

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial is a research paper published in Journal of Internal Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (25 grants)OA: hybridTopics (31)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Ingrid Lilienthal ORCID,Nikolaos Tsesmetzis,Magda Lourda ORCID,Sofia Bengtzén,Anna Bohlin

Live enrichment

PubMed:35934913 PMC:PMC9643609

Barncancerfonden

Grant: TJ2018‐0128

Barncancerfonden

Grant: PR2019‐0100

Barncancerfonden

Grant: TJ2021‐0080

Barncancerfonden

Grant: OA2011‐0001

Barncancerfonden

Grant: KP2018‐0005

Barncancerfonden

Grant: PR2018‐0016

Barncancerfonden

Grant: PR2020‐0077

Barncancerfonden

Grant: TJ2019‐0072

Vetenskapsrådet

Grant: 2017‐06095

Vetenskapsrådet

Grant: 2020‐01184

National Institutes of Health

Grant: AI162633

National Institutes of Health

Grant: AI136581

National Institutes of Health

Grant: MH116695

Cancerfonden

Grant: 21 1494 Pj

Cancerfonden

Grant: CAN 2017/517

Sjöbergstiftelsen

Grant: 2020‐008

Radiumhemmets Forskningsfonder

Grant: 191112

Radiumhemmets Forskningsfonder

Grant: 211143

Svenska Läkaresällskapet

Grant: SLS‐875361

Svenska Läkaresällskapet

Grant: SLS‐961737

NIAID NIH HHS

Grant: R01 AI162633

NIMH NIH HHS

Grant: R01 MH116695

NIAID NIH HHS

Grant: R01 AI136581

Swedish Cancer Society

Grant: unidentified

unidentified

Jeanssons Stiftelser

hybridLicense: cc-by-nc

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/joim.13553

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13553

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/joim.13553

repositoryhttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-494487

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9643609

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansNeoplasm Recurrence, LocalHydroxyureaDaunorubicinCytarabineArabinofuranosylcytosine TriphosphateAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteHot TemperatureSAM Domain and HD Domain-Containing Protein 1

Keywords

HydroxyureacytarabineAcute myeloid leukaemiaTargeted TherapySamhd1Precision MedicineCancer och onkologiHot TemperatureDaunorubicinHematologyOriginal ArticlesSAM Domain and HD Domain-Containing Protein 1Leukemia, Myeloid, AcuteCancer and OncologyAntineoplastic Combined Chemotherapy ProtocolsArabinofuranosylcytosine TriphosphateHumansHematologiNeoplasm Recurrence, Local

Sustainable Development Goals

SDG 3: 3. Good health